Pathophysiology of Drug-Induced Hypomagnesaemia

Drug Saf. 2020 Sep;43(9):867-880. doi: 10.1007/s40264-020-00947-y.

Abstract

Magnesium (Mg2+) is the second most abundant intracellular and fourth extracellular cation found in the body and is involved in a wide range of functions in the human cell and human physiology. Its role in most of the enzyme processes (ATP-ases)-stabilisation of nucleic acids (DNA, RNA), regulation of calcium and potassium ion channels, proliferation, glucose metabolism and apoptosis-make it one of the most important cations in the cell. Three pathogenetic mechanisms are mainly implicated in the development of hypomagnesaemia: reduced food intake, decreased intestinal absorption and increased renal excretion of Mg2+. This review presents the function of Mg2+, how it is handled in the kidney and the drugs that cause hypomagnesaemia. The frequency and the number of drugs like diuretics and proton-pump inhibitors (PPIs) that are used daily in medical practice are discussed in order to prevent and treat adverse effects by providing an insight into Mg2+ homeostasis.

Publication types

  • Review

MeSH terms

  • Diuretics / adverse effects*
  • Humans
  • Magnesium Deficiency / chemically induced*
  • Magnesium Deficiency / physiopathology
  • Proton Pump Inhibitors / adverse effects*

Substances

  • Diuretics
  • Proton Pump Inhibitors